Mucin 4 is a cellular biomarker of necrotizing bronchiolitis in influenza A virus infection.

[1]  Gregg A. Duncan,et al.  Membrane-Tethered Mucin 1 Is Stimulated by Interferon and Virus Infection in Multiple Cell Types and Inhibits Influenza A Virus Infection in Human Airway Epithelium , 2022, mBio.

[2]  N. Bertho,et al.  The pig as a medical model for acquired respiratory diseases and dysfunctions: An immunological perspective. , 2021, Molecular immunology.

[3]  T. Käser Swine as biomedical animal model for T-cell research-Success and potential for transmittable and non-transmittable human diseases. , 2021, Molecular immunology.

[4]  R. Main,et al.  Visualization and application of disease diagnosis codes for population health management using porcine diseases as a model , 2021, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[5]  Gregg A. Duncan,et al.  Influenza A virus diffusion through mucus gel networks , 2020, Communications Biology.

[6]  S. Boxer,et al.  Membrane-tethered mucin-like polypeptides sterically inhibit binding and slow fusion kinetics of influenza A virus , 2019, Proceedings of the National Academy of Sciences.

[7]  Rasna W Walia,et al.  ISU FLUture: a veterinary diagnostic laboratory web-based platform to monitor the temporal genetic patterns of Influenza A virus in swine , 2018, BMC Bioinformatics.

[8]  Ivo M Foppa,et al.  Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness , 2018, Influenza and other respiratory viruses.

[9]  Katharina Ribbeck,et al.  The particle in the spider's web: transport through biological hydrogels. , 2017, Nanoscale.

[10]  L. Ostrowski,et al.  Cilia and Mucociliary Clearance. , 2017, Cold Spring Harbor perspectives in biology.

[11]  L. Brown,et al.  The cell surface mucin MUC1 limits the severity of influenza A virus infection , 2017, Mucosal Immunology.

[12]  R. Prather,et al.  Swine models, genomic tools and services to enhance our understanding of human health and diseases , 2017, Lab Animal.

[13]  R. Webster,et al.  The Interaction between Respiratory Pathogens and Mucus. , 2016, Cell host & microbe.

[14]  Akiko Iwasaki,et al.  Innate immunity to influenza virus infection , 2014, Nature Reviews Immunology.

[15]  P. Taylor,et al.  Interleukin‐6 limits influenza‐induced inflammation and protects against fatal lung pathology , 2013, European journal of immunology.

[16]  Oliver Lieleg,et al.  Mucin biopolymers as broad-spectrum antiviral agents. , 2012, Biomacromolecules.

[17]  F. Clubb,et al.  Swine as Models in Biomedical Research and Toxicology Testing , 2012, Veterinary pathology.

[18]  J. Widdicombe,et al.  Cystic fibrosis and the relationship between mucin and chloride secretion by cultures of human airway gland mucous cells. , 2011, American journal of physiology. Lung cellular and molecular physiology.

[19]  J. Fahy,et al.  Airway mucus function and dysfunction. , 2010, The New England journal of medicine.

[20]  Jeannette Guarner,et al.  Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses. , 2009, Archives of medical research.

[21]  Yan Zhang,et al.  Characterization of an influenza A virus isolated from pigs during an outbreak of respiratory disease in swine and people during a county fair in the United States. , 2009, Veterinary microbiology.

[22]  S. Batra,et al.  Structure, evolution, and biology of the MUC4 mucin , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  V. Korolik,et al.  Mucins in the mucosal barrier to infection , 2008, Mucosal Immunology.

[24]  M. McGuckin,et al.  Structure and function of the polymeric mucins in airways mucus. , 2008, Annual review of physiology.

[25]  S. Gendler,et al.  Structure and function of the cell surface (tethered) mucins. , 2008, Annual review of physiology.

[26]  C. A. Carraway,et al.  Sequestration and Segregation of Receptor Kinases in Epithelial Cells: Implications for ErbB2 Oncogenesis , 2007, Science's STKE.

[27]  P. Singh,et al.  Cell surface-associated mucins in signal transduction. , 2006, Trends in cell biology.

[28]  E. Thacker,et al.  The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination. , 2006, Veterinary immunology and immunopathology.

[29]  S. Brody,et al.  Influenza Virus Receptor Specificity and Cell Tropism in Mouse and Human Airway Epithelial Cells , 2006, Journal of Virology.

[30]  Cary Lai,et al.  The Mucin Muc4 Potentiates Neuregulin Signaling by Increasing the Cell-surface Populations of ErbB2 and ErbB3* , 2006, Journal of Biological Chemistry.

[31]  Erik K. Malm,et al.  A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics* , 2005, Molecular & Cellular Proteomics.

[32]  K. Carraway,et al.  Presence of MUC4 in human milk and at the luminal surfaces of blood vessels , 2005, Journal of cellular physiology.

[33]  G. Whittaker,et al.  Influenza virus entry and infection require host cell N-linked glycoprotein , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. V. von Herrath,et al.  Molecular and cellular control of T1/T2 immunity at the interface between antimicrobial defense and immune pathology. , 2004, DNA and cell biology.

[35]  M. Knowles,et al.  Mucus clearance as a primary innate defense mechanism for mammalian airways. , 2002, The Journal of clinical investigation.

[36]  C. A. Carraway,et al.  Muc4/Sialomucin Complex in the Mammary Gland and Breast Cancer , 2001, Journal of Mammary Gland Biology and Neoplasia.

[37]  G. Apodaca,et al.  Clathrin-mediated endocytosis of MUC1 is modulated by its glycosylation state. , 2000, Molecular biology of the cell.

[38]  N. Moniaux,et al.  Complete sequence of the human mucin MUC4: a putative cell membrane-associated mucin. , 1999, The Biochemical journal.

[39]  C. A. Carraway,et al.  An Intramembrane Modulator of the ErbB2 Receptor Tyrosine Kinase That Potentiates Neuregulin Signaling* , 1999, The Journal of Biological Chemistry.

[40]  A. Wanner,et al.  Mucociliary clearance in the airways. , 1996, American journal of respiratory and critical care medicine.

[41]  P. Halbur,et al.  Comparison of the Pathogenicity of Two US Porcine Reproductive and Respiratory Syndrome Virus Isolates with that of the Lelystad Virus , 1995, Veterinary pathology.

[42]  C. A. Carraway,et al.  Tumor sialomucin complexes as tumor antigens and modulators of cellular interactions and proliferation. , 1992, Journal of cell science.

[43]  K. Carraway,et al.  Molecular cloning of the transmembrane component of the 13762 mammary adenocarcinoma sialomucin complex. A new member of the epidermal growth factor superfamily. , 1992, The Journal of biological chemistry.

[44]  J. Shelhamer,et al.  Human respiratory mucus. , 1984, The American review of respiratory disease.

[45]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .

[46]  J. Voynow,et al.  Respiratory tract mucin genes and mucin glycoproteins in health and disease. , 2006, Physiological reviews.

[47]  C. A. Carraway,et al.  Multiple facets of sialomucin complex/MUC4, a membrane mucin and erbb2 ligand, in tumors and tissues (Y2K update). , 2000, Frontiers in bioscience : a journal and virtual library.